A look back at care and survival for older adults with glioblastoma
Original title: Real-world evidence on the management and outcomes of glioblastoma in elderly patients: a monocentric retrospective analysis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This study only looked back at records of patients who were already treated.
The short version
Doctors reviewed the records of 63 older adults with this brain tumor to see how they were treated and how long they lived.
What was studied. Doctors looked back at records of 63 patients aged 65 years or older with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary. All were cared for at one hospital's radiation department between 2014 and 2023.
What they found. Typical survival was 7.0 months after diagnosis. The typical time before the tumor grew again was 5.3 months. Patients who did not get the chemo drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary had a higher risk of dying, and a higher risk of the tumor growing again.
What this means, and what it doesn't
What it could mean: This is a look back at real patients, not a test of something new. It adds support for giving temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary to older adults who can handle it. If you or a loved one is older, ask the doctor what treatment fits your health and your goals.
What it doesn't mean: This is not a new treatment, and it is not a cure. It does not promise anyone more time. The study only looked back at charts from one hospital, and the group was small. Sicker patients may have been given less treatment, which can make the numbers look a certain way. The authors say these findings only raise ideas that need testing, not proof that one choice caused a better result.
Source: PubMed, October 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.